NDC 72606-045 – Avtozma
Tocilizumab 162 mg/.9mL · Injection, Solution · Subcutaneous
Product NDC72606-045
Product details
- Brand name
- Avtozma
- Generic name
- Tocilizumab
- Labeler
- CELLTRION USA, Inc.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761498
- Marketed since
- February 1, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-6 Receptor Antagonist
Active ingredients
- Tocilizumab 162 mg/.9mL
Package NDC codes (6)
| Package NDC | Description | Since |
|---|---|---|
| 72606-045-01 | 1 SYRINGE, GLASS in 1 CARTON (72606-045-01) / .9 mL in 1 SYRINGE, GLASS | Feb 1, 2026 |
| 72606-045-02 | 4 SYRINGE, GLASS in 1 CARTON (72606-045-02) / .9 mL in 1 SYRINGE, GLASS | Feb 1, 2026 |
| 72606-045-03 | 12 SYRINGE, GLASS in 1 CARTON (72606-045-03) / .9 mL in 1 SYRINGE, GLASS | Feb 1, 2026 |
| 72606-045-04 | 1 SYRINGE, GLASS in 1 CARTON (72606-045-04) / .9 mL in 1 SYRINGE, GLASS | Feb 1, 2026 |
| 72606-045-05 | 4 SYRINGE, GLASS in 1 CARTON (72606-045-05) / .9 mL in 1 SYRINGE, GLASS | Feb 1, 2026 |
| 72606-045-06 | 12 SYRINGE, GLASS in 1 CARTON (72606-045-06) / .9 mL in 1 SYRINGE, GLASS | Feb 1, 2026 |